Implementation of Pharmacy-Based Vaccination against Human Papillomavirus: A scoping review of literature
Abstract
In most EU countries, pharmacists as community-based health care professionals (HCPs) can provide education and vaccination services, which can enhance convenience and accessibility for patients. This is especially important in areas where vaccine-coverage rates (VCRs) are suboptimal and in underserved areas where access to healthcare practitioners (HCPs) may be limited.
The aim of this review is to describe the impact and feasibility of Human Papillomavirus (HPV) - related pharmacy-based vaccination (PBV) programs. The findings indicate that expanding access to vaccinations through pharmacies has the potential to improve immunization rates, particularly in underserved or hard-to-reach populations. Pharmacists’ roles as advocates, educators, and vaccine providers can address barriers, improve awareness, and promote vaccination uptake. Collaboration with other HCPs is essential enabling a comprehensive approach to HPV vaccination promotion.
In conclusion, PBV programs have the potential to serve as an effective strategy for improving immunization rates in both rural and urban areas. The integration of pharmacies, through multi-disciplinary approach into HPV immunization programs can expand access, spread awareness, provide education, clarify concerns, increase convenience, and reach underserved populations. However, careful planning, training, and collaboration with other HCPs such as physicians and nurses, are necessary to overcome challenges and ensure the safe and efficient delivery of vaccines through pharmacies.
References
Leveraging pharmacy to deliver life-course vaccination [Internet]. FIP report; 2024 [cited 2024 Nov 30]. Available from: https://www.fip.org/file/5848.
PGEU Pharmacy 2030: A vision for Community Pharmacy in Europe. Available from: https://www.pgeu.eu/publications/pharmacy-2030-a-vision-for-community-pharmacy-in-europe/.
Human Papillomavirus (HPV) [Internet]. Centers for Disease Control and Prevention (CDC); 2021 [cited 2024 Nov 30]. Available from: https://www.cdc.gov/hpv/parents/vaccine-for-hpv.html.
Vaccine Scheduler [Internet]. European Centre for Disease Prevention and Control (ECDC); 2021 [cited 2024 Nov 30]. Available from: https://vaccineschedule.ecdc.europa.eu/https://www.ema.europa.eu/en/medicines/human/EPAR/gardasil-9.
Immunization, Vaccines, and Biologicals - HPV Vaccine [Internet]. World Health Organization (WHO); 2021 [cited 2024 Nov 30]. Available from: https://www.who.int/immunization/diseases/hpv/en/.
Szymonowicz KA, Chen J. Biological and clinical aspects of HPV-related cancers. Cancer Biol Med. 2020;17(4):864–78.
Jit M, Prem K, Benard E, Brisson M. From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness. Prev Med. 2021;144:106354.
de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180-90.
Rajković D, Filipić B, Tadić I, Rakić M, Trunić M, Letić B, et al. Strengthening the role of the community pharmacy in HPV Vaccination Roll-out in Serbia at National and Local Levels [abstract]. In: IV Congress of Pharmacists of Montenegro with international participation; 2023 May 11–14; Budva, Bečići, Montenegro. p. 44.
Power BI WHO dashboard [Internet]. Geneva: World Health Organization; [cited 2025 Jan 26]. Available from: https://app.powerbi.com/view?r=eyJrIjoiNDIxZTFkZGUtMDQ1Ny00MDZkLThiZDktYWFlYTdkOGU2NDcwIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9
Partnership to Contrast HPV (PERCH project) [Internet]. European Union; 2023 [cited 2025 Jan 26]. Available from: https://health.ec.europa.eu/non-communicable-diseases/cancer/europes-beating-cancer-plan-eu4health-financed-projects/projects/perch_en
WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer [Internet]. World Health Organization (WHO); 2020 [cited 2025 Jan 26]. Available from: https://www.uicc.org/what-we-do/driving-global-impact/targeted-commitments/global-strategy-elimination-cervical-cancer
Gardasil 9 human papillomavirus 9-valent vaccine (recombinant, adsorbed) [Internet]. European Medicines Agency; 2024 [cited 2025 Jan 26]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/gardasil-9.
Dougherty S, Hayney MS. HPV9: Combating HPV-associated cancers by strengthening serotype defenses. J Am Pharm Assoc. 2025;55(6):670–2.
Filipic B, Rapajic-Moran I, Nikolic I, Oljacic S. Human papilloma viruses and cervical cancer from the perspective of the World Health Organization initiative for cervical cancer elimination. Arh farm. 2024;74:56–75.
Calo WA, Shah PD, Gilkey MB, Vanderpool RC, Barden S, Doucette WR, Brewer NT. Implementing pharmacy-located HPV vaccination: findings from pilot projects in five US states. Hum Vaccin Immunother. 2019. doi: 10.1080/21645515.2019.1602433.
Hastings TJ, Hohmann LA, McFarland SJ, Teeter BS, Westrick SC. Pharmacists’ attitudes and perceived barriers to human papillomavirus (hpv) vaccination: A systematic literature review. Vaccines. 2021;9(11):1360.
Islam JY, Gruber JF, Kepka D, Kunwar M, Smith SB, Rothholz MC, et al. Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States. Hum Vaccin Immunother. 2019. doi:10.1080/21645515.2018.1556077.
Hohmeier KC, Randolph DD, Smith CT, Hagemann TM. A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting. SAGE Open Med. 2016;4. doi: 10.1177/2050312116682128.
Shah PD, Calo WA, Marciniak MW, Gilkey MB, Brewer NT. Support for pharmacist-provided HPV vaccination: National surveys of US physicians and parents. Cancer Epidemiol Biomarkers Prev. 2018;27(8):970–8.
Teeter BS, Mosley C, Thomas JL, Martin B, Jones D, Romero JR, Curran GM. Improving HPV vaccination using implementation strategies in community pharmacies: Pilot study protocol. Res Social Adm Pharm. 2020;16(3):336–41.
Maples JM, Zite NB, Oyedeji O, Chamberlin SM, Mastronardi AM, Gregory S, et al. Availability of the HPV vaccine in regional pharmacies and provider perceptions regarding HPV vaccination in the pharmacy setting. Vaccines. 2022;10(3):351.
Daniel CL, Lawson F, Vickers M, Green C, Wright A, Coyne-Beasley T, et al. Enrolling a rural community pharmacy as a Vaccines for Children provider to increase HPV vaccination: a feasibility study. BMC Public Health. 2021. doi: 10.1186/s12889-021-11304-8.
Brewer NT, Chung JK, Baker HM, Rothholz MC, Smith JS. Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention. Gynecol Oncol. 2014;132:S3-8.
Carney PA, Bumatay S, Kuo GM, Darden PM, Hamilton A, Fagnan LJ, Hatch B. The interface between US primary care clinics and pharmacies for HPV vaccination delivery: A scoping literature review. Prev Med Rep. 2022;28:101893.
Nielsen AR, Hayney MS. Human papillomavirus: a brief overview and recommendations for pharmacists. J Am Pharm Assoc. 2014;54(5):558–61.
Teeter BS, Jensen CR, Thomas JL, Martin BC, McElfish PA, Mosley CL, Curran GM. Perceptions of HPV vaccination and pharmacist-physician collaboration models to improve HPV vaccination rates. Explor Res Clin Soc Pharm. 2021;2:100014.
Koskan A, Zittel ME, Lee C, Sanchez O, Alvarez L, Helitzer DL. The feasibility and acceptability of a pilot randomized controlled trial testing pharmacy-based HPV vaccine completion. Res Social Adm Pharm. 2022;18(6):3038–45.
Doucette WR, Kent K, Seegmiller L, McDonough RP, Evans, W. Feasibility of a coordinated human papillomavirus (HPV) vaccination program between a medical clinic and a community pharmacy. Pharmacy. 2019;7(3):91.
Rothholz M, Tan L. Promoting the immunization neighborhood: benefits and challenges of pharmacies as additional locations for HPV vaccination. Hum Vaccin Immunother. 2017;13(8):1856–8.
Cernasev A, Hohmeier KC, Oyedeji O, Kintziger KW, Hagemann TM. Views of the Pharmacists’ Role in HPV Vaccinations: A Qualitative Study in Tennessee. Pharmacy. 2024;12(2):57.
Wick JA, Elswick BM. Impact of pharmacist delivered education on early parent awareness and perceptions regarding human papillomavirus (HPV) vaccination in the community pharmacy setting in West Virginia. Innov Pharm. 2018;9(3):1–6.
Koskan A, Vizcaino M, Brennhofer SA, Lee CD, Roberto AJ. Human papillomavirus vaccine administration behaviors and influences among Arizona pharmacists and pharmacy interns. Hum Vaccin Immunother. 2021;17(9):3090–5.
Vanderpool RC, Stradtman LR, Brandt HM. Policy opportunities to increase HPV vaccination in rural communities. Hum Vaccin Immunother. 2019. doi: 10.1080/21645515.2018.1553475.
Navarrete JP, Padilla ME, Castro LP, Rivera JO. Development of a community pharmacy human papillomavirus vaccine program for underinsured university students along the United States/Mexico border. J Am Pharm Assoc. 2014;54(6):642–7.
Cartmell KB, Young-Pierce J, McGue S, Alberg AJ, Luque JS, Zubizarreta M, Brandt HM. Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action. Papillomavirus Res. 2018;5:21–31.
Shah PD, Gilkey MB, Pepper JK, Gottlieb SL, Brewer NT. Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines. 2014;13(2).235–46.
Koskan AM, Dominick LN, Helitzer DL. Rural caregivers’ willingness for community pharmacists to administer the HPV vaccine to their age-eligible children. J Cancer Educ. 2021;36(1):189–98.
Calo WA, Gilkey MB, Shah P, Marciniak MW, Brewer NT. Parents' willingness to get human papillomavirus vaccination for their adolescent children at a pharmacy. Prev Med. 2017;99:251–6.
Trogdon JG, Shafer PR, Shah PD, Calo WA. Are state laws granting pharmacists authority to vaccinate associated with HPV vaccination rates among adolescents? Vaccine. 2016;34(38):4514–9.
Zahnd WE, Harrison SE, Stephens HC, Messersmith AR, Brandt HM, Hastings TJ, Eberth JM. Expanding access to HPV vaccination in South Carolina through community pharmacies: a geospatial analysis. J Am Pharm Assoc. 2020;60(6):e153-7.
Zhang S, Kwach B, Omollo V, Asewe M, Malen R, Shah PD, et al. The Acceptability of Pharmacy-Based HPV Vaccination in Western Kenya among Pharmacy Clients and Providers. Vaccines. 2023;11(12):1808.
Shah PD, Calo WA, Marciniak MW, Golin CE, Sleath BL, Brewer NT. Service quality and parents' willingness to get adolescents HPV vaccine from pharmacists. Prev Med. 2018;109:106–12.
Fava JP, Colleran J, Bignasci F, Cha R, Kilgore PE. Adolescent human papillomavirus vaccination in the United States: opportunities for integrating pharmacies into the immunization neighborhood. Hum Vaccin Immunother. 2017;13(8):1844–55.
Westrick SC, Hohmann LA, McFarland SJ, Teeter BS, White KK, Hastings TJ. Parental acceptance of human papillomavirus vaccinations and community pharmacies as vaccination settings: A qualitative study in Alabama. Papillomavirus Res. 2017;3:24–9.
Tolentino V, Unni E, Montuoro J, Bezzant-Ogborn D, Kepka D. Utah pharmacists' knowledge, attitudes, and barriers regarding human papillomavirus vaccine recommendation. J Am Pharm Assoc. 2018;58(4):S16-23.
Fernandes A, Wang D, Domachowske JB, Suryadevara M. HPV vaccine knowledge, attitudes, and practices among New York state medical providers, dentists, and pharmacists. Hum Vaccin Immunother. 2023;19(2):2219185.
Strasel M, VanLangen KM, Benzer J, Geyer A, Jameson AP, Dumkow LE. HPV vaccination rates in 9-and 10-year-olds following a pharmacist-led intervention. J Am Pharm Assoc. 2024;64(1):278–82.
Bouanani I. HPV Vaccine Administration in Community Pharmacies [Internet]. 2020 [cited 2025 Jan 26]. Available from: https://keep.lib.asu.edu/items/130991.
Shah PD, Trogdon JG, Golden SD, Golin CE, Marciniak MW, Brewer NT. Impact of pharmacists on access to vaccine providers: a geospatial analysis. Milbank Q. 2018;96(3):568–92.
Shah PD. The role of pharmacy in HPV vaccination of US adolescents [Internet]. 2017 [cited 2025 Jan 26]. Available from: https://cdr.lib.unc.edu/concern/dissertations/0g354f698?locale=en.
Cebollero J, Walton SM, Cavendish L, Quairoli K, Cwiak C, Kottke MJ. Evaluation of human papillomavirus vaccination after pharmacist-led intervention: A pilot project in an ambulatory clinic at a Large academic urban medical center. Public Health Rep. 2020;135(3):313–21.
Dufour L, Carrouel F, Dussart C. Human Papillomaviruses in Adolescents: Knowledge, Attitudes, and Practices of Pharmacists Regarding Virus and Vaccination in France. Viruses. 2023;15(3):778.
Iqbal MS, Iqbal MZ, Bahari MB. Effectiveness of pharmacists-led provider-focused interventions to improve HPV vaccination rates in adults in Malaysia. Value Health. 2016;19(7):A424.
Dingman DA, Schmit CD. Authority of pharmacists to administer human papillomavirus vaccine: alignment of state laws with age-level recommendations. Public Health Rep. 2018;133(1):55–63.
Shah PD, Marciniak MW, Golden SD, Trogdon JG, Golin CE, Brewer NT. Pharmacies versus doctors’ offices for adolescent vaccination. Vaccine. 2018;36(24):3453–9.
Yoost J, Ditrapano N, Ranavaya J, Redmond K. Parent and provider views of using pharmacies for HPV vaccination in adolescents. J Pediatr Adolesc Gynecol. 2021;34(2):274–5.
Jiménez-Quiñones EM, Melin K, Jiménez-Ramírez FJ. Impact of a pharmacist conducted educational program on human papilloma virus vaccination rates in a low socioeconomic population in the city of Lares, PR. P R Health Sci J. 2017;36(2):67–70.
Cannon HE. Pharmacy management of vaccines. J Manag Care Pharm. 2007;13(7):S7-11.
Sasaki A, Nakao Y, Obara T, Abe S, Yamaguchi H, Yoshimachi S, Goto T. Knowledge and Attitude towards Cervical Cancer and Human Papillomavirus among Pharmacists in Japan. Asian Pac J Cancer Prev. 2021;22(7):2259-65.
Roman M, Cruz MRD, Soon R, Ma C, Chen, JJ. Understanding Factors Affecting Health Providers’ Perceptions of Pharmacist Roles in HPV Vaccine Administration. Hawaii J Health Soc Welf. 2024;83(4):92–8.
Brown V, Tsuyuki RT. The pharmacist’s role in prevention of HPV-related cancers. Can Pharm J. 2021;154(4):228-31.
Islam JY, Gruber JF, Lockhart A, Kunwar M, Wilson S, Smith SB, et al. Opportunities and challenges of adolescent and adult vaccination administration within pharmacies in the United States. Biomed Inform Insights. 2017. doi: 10.1177/1178222617692538.
Ryan G, Daly E, Askelson N, Pieper F, Seegmiller L, Allred T. Exploring Opportunities to Leverage Pharmacists in Rural Areas to Promote Administration of Human Papillomavirus Vaccine. Prev Chronic Dis. 2020;17:E23.
Skiles MP, Cai J, English A, Ford CA. Retail pharmacies and adolescent vaccination—An exploration of current issues. J Adolescent Health. 2011;48(6):630–2.
Berce PC, Bernstein RS, MacKinnon GE, Sorum S, Martin E, MacKinnon KJ, et al. Immunizations at Wisconsin Pharmacies: Results of a statewide vaccine registry analysis and pharmacist survey. Vaccine. 2020;38(28):4448–56.
Julia B, Farge G, Mourlat B, Mamane C, Bensimon L, Hommel C, Conan G. Facilitating human papillomavirus vaccination pathways by extending vaccination competencies to community pharmacists: A cross-sectional survey on the acceptability and expectations among healthcare professionals and parents. Explor Res Clin Soc Pharm. 2023;10:100255.
Mohamed R, Kelly KM, Nili M, Kelley GA. A systematic review with meta-analysis of parental interventions for human papillomavirus vaccine uptake. J Am Pharm Assoc. 2022;62(4):1142–53.
Corke P, Jones J, Gudka S. Evidence of the Role of Pharmacy-Based Interventions in Sexually Transmitted Infections. In: Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. 2022; p. 581–99. doi.org/10.1007/978-3-030-64477-2_102.
Lutz CS, Kim DK, Black CL, Ball SW, Devlin RG, Srivastav A, et al. Clinicians’ and pharmacists’ reported implementation of vaccination practices for adults. Am J Prev Med. 2018;55(3):308–18.
Lam JH, Singh S, Kuo GM. Comparisons of immunization records between a community pharmacy, a regional registry, and a health system. J Am Pharm Assoc. 2019;59(1):30–4.
Palmer J, Carrico C, Costanzo C. Identifying and overcoming perceived barriers of providers towards HPV vaccination: a literature review. J Vaccin. 2015;1:869468.
Strand MA, Mager NAD, Hall L, Martin SL, Sarpong DF. Pharmacy contributions to improved population health: expanding the public health roundtable. Prev Chronic Dis. 2020;17:E113.
Rubin R. Why the “no-brainer” HPV vaccine is being ignored. Jama. 2015;313(15):1502–4.
Herrman A, Ruisinger JF, Moore EE, Melton BL. Assessing the impact of a pharmacy-provided personalized vaccination recommendation on immunization rates of adolescents. J Am Pharm Assoc. 2023;63(4):S43-7.
Rothholz MC. The role of community pharmacies/pharmacists in vaccine deliver in the United States [Internet]. 2013 [cited 2025 Jan 26]. Available from: https://stacks.cdc.gov/view/cdc/76424/cdc_76424_DS1.pdf.
Chadi A, Thirion DJG, David PM. Vaccine promotion strategies in community pharmacy addressing vulnerable populations: a scoping review. BMC Public Health. 2023;23(1):1855.
DiTrapano N, Redmond K, Ranavaya J, Yoost J. Appalachian Parent and Provider Views on the Use of Pharmacies for Human Papillomavirus Vaccination in Adolescents. Marshall J Med. 2022;8(2):5.
Westrick SC, Patterson BJ, Kader MS, Rashid S, Buck PO, Rothholz MC. National survey of pharmacy-based immunization services. Vaccine. 2018;36(37):5657–64.
McRee AL, Reiter PL, Pepper JK, Brewer NT. Correlates of comfort with alternative settings for HPV vaccine delivery. Hum Vaccin Immunother. 2013;9(2):306–13.
Targhotra M, Dhamoon RK, Verma S. Cervical Cancer- A Disease Affecting Millions Sch. Acad. J. Pharm. 2018; 7(2): 99-104. doi: 10.21276/sajp.2018.7.2.6
Isenor JE, Bowles SK. Opportunities for pharmacists to recommend and administer routine vaccines. Can Pharm J. 2019;152(6):401–5.
Brandt HM, Vanderpool RC, Curry SJ, Farris P, Daniel-Ulloa J, Seegmiller L, et al. A multi-site case study of community-clinical linkages for promoting HPV vaccination. Hum Vaccin Immunother. 2019;15:1599–606.
Nguyen-Huu NH, Thilly N, Derrough T, Sdona E, Claudot F, Pulcini C, Agrinier N. HPV Policy Working Group. Human papillomavirus vaccination coverage, policies, and practical implementation across Europe. Vaccine. 2020;38(6):1315–31.
Houle SKD, Alsabbagh MW, Waite NM. Herpes zoster and human papillomavirus vaccination opportunities identified using electronic prompts at the time of scheduling influenza or COVID-19 vaccines. Can Pharm J. 2023;156(5):257–64.
Pittman E, Ford MA, Barnard M, Tschumpter E, Earl S, Gautreaux J. Launching a Human Papillomavirus Vaccination (HPV) Campaign on a College Campus during the COVID-19 Pandemic. J Public Health Deep South. 2022;3(1):8.
Philbrick AM, Frail CK, Rhee TG. Human Papillomavirus Vaccine: An Opportunity for Minnesota Pharmacists to Impact Public Health. J Am Pharm Assoc. 2018; 58:S16-23 doi.org/10.1016/j.japh.2018.04.014
Gonzalez PR, Black EK, Trenaman S, Wilby KJ. Improving equity of services for sexually transmitted infections through community pharmacies: a scoping review. J Am Pharm Assoc. 2024;64(1):197-203.e2.
Risley C, Filzen AF, Ellis A, Jones SM, Tucker L, Farrington K, et al. Opening New Pathways to HPV Cancer Prevention through Changes in Practice, Policy, and Partnerships. Acad Sci. 2022;67:396.
Hogue MD, Foster S, Rothholz MC. Shared clinical decision making on vaccines: Nothing has really changed for pharmacists. J Am Pharm Assoc. 2020;60(6):e91-4.
Richman AR, Haithcox-Dennis MJ, Allsbrook AR. Feasibility of a catch-up HPV vaccination program among college students attending a large rural university in the south. Am J Sex Educ. 2012;7(3):237–52.
Levy MS, Finch L, Lindsay KA, Jeudin P, Huang M. Leveraging teachable moments in cancer prevention by improving HPV vaccination in health professional students (HPS): A systematic review. Front Oncol. 2022;12:978843.
Welch AC. Pharmacist immunization services evolving for multiple-dose series. J Am Pharm Assoc. 2016;56(4):467–70.
Koskan A, Brennhofer SA, Helitzer D. Administering the HPV Vaccine to People Living with HIV: Providers’ Perspectives. J Prim Prev. 2020;41(4):349–62.
Oleksyn C. The role of pharmacists in providing recommended vaccines. Can Pharm J. 2019;152(6):406–10.
Valentino K, Poronsky CB. Human papillomavirus infection and vaccination. J Pediatr Nurs. 2016;31(2):e155-66.
Peterson CE, Silva A, Holt HK, Balanean A, Goben AH, Dykens JA. Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review. Cancer Causes Control. 2020;31:801–14.
Klein K, Luedtke S. Advocacy Committee of the Pediatric Pharmacy Advocacy Group. Human papillomavirus vaccination: a case for mandatory immunization? J Pediatr Pharmacol Ther. 2008;13(1):47–50.
Weygandt J. A comprehensive multi-level approach to increasing HPV vaccination rates in rural Kentucky [Internet]. 2017 [cited 2025 Jan 26]. Available from: https://uknowledge.uky.edu/cph_etds/154.
Baroy J, Chung D, Frisch R, Apgar D, Slack MK. The impact of pharmacist immunization programs on adult immunization rates: a systematic review and meta-analysis. J Am Pharm Assoc. 2016;56(4):418–26.
Navarrete J, Yuksel N, Schindel TJ, Hughes CA. Sexual and reproductive health services provided by community pharmacists: a scoping review. BMJ Open. 2021;11(7):e047034.
White MC, Osazuwa-Peters OL, Abouelella DK, Barnes JM, Cannon TY, Watts TL, et al. Trends and factors associated with receipt of human papillomavirus (HPV) vaccine in private, public, and alternative settings in the United States. Vaccine. 2024;42(22):126036.
Christy SM, Fuzzell LN, Lake PW, Staras S, Colon LV, Best A, Hull PC, Vadaparampil ST. Community-Based Interventions for HPV Vaccination. In: Cancer Health Disparities: From Determinants of Disparities to Solutions for Equity. Springer 2023; p. 147–81.
Stupiansky NW, Rosenthal SL, Wiehe SE, Zimet GD. Human papillomavirus vaccine acceptability among a national sample of adult women in the USA. Sex Health. 2010;7(3):304–09.
Kombe AJK, Zoa-Assoumou S, Bounda GA, Nsole-Biteghe FA, Jin T, Zouré AA. Advances in Etiopathological Role and Control of HPV in Cervical Cancer Oncogenesis. Front Biosci (Landmark Ed). 2023;28(10):245.
Carney PA, Bumatay S, Kuo GM, Darden PM, Hamilton A, Fagnan LJ, Hatch B. The interface between U.S. primary care clinics and pharmacies for HPV vaccination delivery: A scoping literature. Prev Med Rep. 2022;28:101893.
Easwaran V, Shorog EM, Alshahrani AA, Mohammad AAS, Sadiq MMJ, Alavudeen SS, et al. Knowledge, Attitudes, and Practices Related to Cervical Cancer Prevention and Screening among Female Pharmacy Students at a Public University in a Southern Region of Saudi Arabia. Healthcare (Basel). 2023;11(20):2798.
Shah PD, Calo WA, Marciniak MW, Gilkey MB, Brewer NT. Support for Pharmacist-Provided HPV Vaccination: National Surveys of U.S. Physicians and Parents. Cancer Epidemiol Biomarkers Prev. 2018;27(8):970–8.
Finch LA, Levy MS, Thiele A, Jeudin P, Huang M. Barriers to cervical cancer prevention in a safety net clinic: gaps in HPV vaccine provider recommendation and series completion among Ob/Gyn patients. Front Oncol. 2024;14:1359160.
Agana-Norman DFG, Martinez Martinez M, Shanmugasundaram M, Berenson AB. Understanding Barriers to Human Papillomavirus Vaccination among Parents of 9-10-Year-Old Adolescents: A Qualitative. Vaccines (Basel). 2024;12(3):245.
Curran G, Mosley C, Gamble A, Painter J, Ounpraseuth S, Brewer NT, et al. Addressing COVID-19 vaccine hesitancy in rural community pharmacies: a protocol for a stepped wedge randomized clinical trial. Implement Sci. 2023;18(1):72.
Daniel CL, Wright AR. Increasing HPV Vaccination in Rural Settings: The Hidden Potential of Community Pharmacies. J Rural Health. 2020;36(4):465–7.
Cataldi JR, Brewer SE, Perreira C, Furniss A, Nederveld A, Suresh K, et al. Rural Adolescent Immunization: Delivery Practices and Barriers to Uptake. J Am Board Fam Med. 2021;34(5):937–49.
Grabenstein JD. High expectations: standards and guidelines for immunization delivery. Hosp Pharm. 2000;35:841–51.
